Algert Global LLC Takes Position in The Cooper Companies, Inc. $COO

Key Points

• Algert Global LLC initiated a position in Cooper Companies by purchasing 106,750 shares valued at approximately $7.7 million, representing 0.05% of the company. Institutional investors and hedge funds collectively own 24.39% of COO.
• Cooper Companies reported quarterly EPS of $1.21, exceeding estimates of $1.10, while revenue rose 7.9% year over year to $1.08 billion. The company provided fiscal 2026 EPS guidance of $4.58–$4.66.
• COO opened at $72.68, near its 50-day moving average, and analysts have a consensus “Hold” rating with an average price target of $81.64, despite mixed recent rating changes.

Algert Global LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The fund bought 106,750 shares of the medical device company's stock, valued at approximately $7,655,000. Algert Global LLC owned 0.05% of Cooper Companies as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of COO. BlackRock Inc. acquired a new position in shares of Cooper Companies during the 2nd quarter valued at $1,077,762,000. State Street Corp increased its holdings in Cooper Companies by 2.4% in the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company's stock valued at $720,736,000 after purchasing an additional 207,195 shares in the last quarter. Wellington Management Group LLP raised its position in Cooper Companies by 332.9% in the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company's stock valued at $424,043,000 after purchasing an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD raised its position in Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company's stock valued at $494,123,000 after purchasing an additional 2,231,568 shares during the period. Finally, Generation Investment Management LLP acquired a new position in shares of Cooper Companies during the second quarter worth about $356,304,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Trading Down 0.5%

NASDAQ COO opened at $72.68 on Thursday. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a 50-day simple moving average of $72.36 and a 200-day simple moving average of $70.96. The firm has a market capitalization of $14.17 billion, a PE ratio of 61.59, a price-to-earnings-growth ratio of 1.91 and a beta of 0.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The firm had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. During the same quarter in the prior year, the business earned $0.96 earnings per share. Cooper Companies's quarterly revenue was up 7.9% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on COO shares. Wall Street Zen raised Cooper Companies from a "hold" rating to a "buy" rating in a research report on Sunday, June 21st. KeyCorp reaffirmed a "sector weight" rating on shares of Cooper Companies in a research report on Friday, June 5th. Citigroup reiterated a "neutral" rating and set a $80.00 price objective (up from $76.00) on shares of Cooper Companies in a research note on Thursday, August 13th. Weiss Ratings cut shares of Cooper Companies from a "hold (c-)" rating to a "sell (d)" rating in a research report on Monday, June 8th. Finally, BNP Paribas Exane decreased their target price on shares of Cooper Companies from $95.00 to $92.00 and set an "outperform" rating for the company in a research note on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $81.64.

Cooper Companies Profile

Cooper Companies, Inc NASDAQ: COO is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women's health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source